University of Oxford and PrecisionLife reach data agreement
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis
Read Moreby John Pinching | Jun 29, 2023 | News | 0
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis
Read Moreby John Pinching | Jun 23, 2023 | News | 0
Companies’ precision medicine approach has potential to increase clinical trial success rates
Read Moreby John Pinching | Apr 25, 2023 | News | 0
The link-up will enable the company to identify new motor neurone disease biomarkers
Read Moreby John Pinching | Dec 14, 2022 | News | 0
R&D partnership will identify and develop novel therapeutic targets for future therapies
Read Moreby John Pinching | Sep 14, 2022 | News | 0
Study reveals first genetic links in chronic fatigue syndrome, paving the way for new drugs
Read Moreby John Pinching | May 11, 2022 | News | 0
The project will analyse risks from Sano Genetics’ data from 3,000 UK adults suffering from long COVID
Read Moreby Selina McKee | May 14, 2020 | News | 0
An analysis of UK Biobank datasets by PrecisionLife has found 13 ‘druggable’ targets
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
